MSB 2.12% 92.5¢ mesoblast limited

Australian newspaper article, page-134

  1. 1,472 Posts.
    lightbulb Created with Sketch. 3237
    Hi @nippy,

    I understand OTP senior management work closely with leal and regulatory specialists e.g. its internal Office of Review Management and Regulatory Review. But OTP's own top-level structure has a fair degree of regulatory oversight built into it now. De-bottlenecking and harmonising of conflicting objecives are a couple of the reasons why OTP was formed. I could be wrong but I'm not sure having an external legal person ask pointed questions would really move things along that much faster in Type A (much less Type C) meetings. Could even slow things down atm.

    But I was heartened to read in the 'paper article words along the lines of "...we re-presented our data to a group of the leadership around a table... ". That indicated to me that, as a team, senior OTP regulatory oversight is likely making certain the process stays on the rails this time. @Lopez has (IMO properly) mentioned a couple of times the significance of Dr N. Verdun - the Super Office Director - attending a sponsor-review team meeting in person.

    I suspect the number of product development review meetings that Dr Verdun attends in person could be counted on a very few hands. And maybe even fingers.

    Cheers
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
92.5¢
Change
-0.020(2.12%)
Mkt cap ! $1.056B
Open High Low Value Volume
93.0¢ 93.5¢ 92.0¢ $2.103M 2.270M

Buyers (Bids)

No. Vol. Price($)
11 106422 92.5¢
 

Sellers (Offers)

Price($) Vol. No.
93.0¢ 59027 3
View Market Depth
Last trade - 16.10pm 09/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.